Patient Care Interdisciplinary Approach Provides Best Possible Care for Patients with Prostate Cancer By URMC Communications Nov. 15, 2023 Prostate cancer patients benefit for a unique team-based care model that brings together urologists, medical oncologists, radiation oncologists, surgical oncologists, and pathologists.
Research Science Backs Mind-Body Tools Like Meditation and Music for Cancer-Related Anxiety By Leslie Orr Aug. 30, 2023 Science now supports several mind-body interventions - meditation, yoga, acupuncture, music therapy, for example- and a Wilmot faculty member was on the national panel.
Patient Care The Current and Future Role of Single-Port Robotic Surgery By Mark Michaud Aug. 4, 2023 The da Vinci single port robotic surgical system, which made its clinical debut in 2018, represents a significant technological advance in robotic surgery.
Patient Care Single-Port Robotic System Augments URMC Clinical Expertise, Spurs Innovation and Training By Karin Christensen Feb. 21, 2022 URMC continues to lead the field of robotic surgery, utilizing the fourth-generation, single-port Intuitive da Vinci SP to provide patients the most precise surgical option available, and applying ...
People Incoming AUA President Continuing the Leadership Tradition of URMC Urologists By URMC Communications Feb. 21, 2022 When Edward Messing assumes the American Urological Association presidency in May 2022, he will follow in the footsteps of other leaders in the field from URMC.
Patient Care It's Men’s Health Month: Be Your Own Advocate and Know Family History, Says Prostate Cancer Survivor By Ruth Harper-Rhode Jun. 20, 2021 Tim McConnell has always been an advocate for his own health, and he knew he had a higher chance of developing prostate cancer because his father had two prostate cancer surgeries during the course ...
Research UR Awarded $29 Million for National Leadership in Cancer Control Research By Leslie Orr Sep. 30, 2019 UR Medicine’s Wilmot Cancer Institute is continuing its practice-changing research into cancer side-effects and symptom management with a coveted $29 million grant from the National Cancer ...
Research Prostate Cancer Researchers Find Molecular “Switch” to Prolong Survival By Leslie Orr Jun. 12, 2019 Wilmot Cancer Institute scientists believe they have figured out why a commonly used drug to treat late-stage prostate cancer stops working after four or five months and appears to have a dual ...
Patient Care Watch for Wilmot during 2019 Super Bowl By Ruth Harper-Rhode Jan. 31, 2019 UR Medicine’s Wilmot Cancer Institute will be featured in a commercial that will air during the 2019 Super Bowl, which starts at 6:30 p.m. on Sunday, Feb. 3. The ad highlights several key facts about ...
Research Messing Honored for Career of Innovation and Leadership in Urological Care By Mark Michaud Oct. 22, 2018 Leading researchers and clinicians from across the globe gathered in Rochester on October 18-19 to recognize the career of Edward Messing, M.D., F.A.C.S., and his 35 years of accomplishments in ...
